News Daily News Ischemic vs Bleeding Risks: Do Antiplatelet Guidelines Need Rethinking? Yael L. Maxwell January 23, 2025
News Daily News Benefits of Various SGLT2 Inhibitors Mostly Consistent in Observational Study Michael O'Riordan January 22, 2025
News Daily News Lost Chances: Medicare Analysis Says Preamputation Vascular Care Eludes Many L.A. McKeown January 16, 2025
News Daily News Mobile Health for Cardiac Rehab Doesn’t Aid Older Adults With CVD: RESILIENT Caitlin E. Cox January 15, 2025
News Daily News BMJ Investigation Revives Questions About PLATO, Ticagrelor Todd Neale December 20, 2024
News Daily News PREDIMED Analysis May Rekindle Hope for Wine’s Heart Benefits Michael O'Riordan December 18, 2024
News Daily News Sudden Cardiac Death in Athletes Is Rare, but Affects Black Population More Michael O'Riordan December 06, 2024
News Daily News CVD Risks Vary by Type of Menopausal Hormone Replacement Therapy Todd Neale December 04, 2024
News Daily News Increased CVD Risk Seen Up to 30 Years Before Type 2 Diabetes Diagnosis Todd Neale November 28, 2024
News Conference News AHA 2024 ZODIAC: Decision-Support Tool Doesn’t Sway Lipid-Lowering Treatments in ACS Michael O'Riordan November 21, 2024
News Conference News AHA 2024 Two Lp(a)-Lowering Therapies Clear Bar in KRAKEN and ALPACAR-360 Michael O'Riordan November 18, 2024
Presentation AHA 2024 OptimiZation Of Lipid Lowering Therapies Using A Decision Support System In Patients With Acute Coronary Syndrome (ZODIAC): A Randomized Controlled Trial Presenter: Kausik K. Ray November 17, 2024
News Conference News AHA 2024 Email Nudges Spur Patients With a History of Acute MI to Get Flu Shots Caitlin E. Cox November 17, 2024
News Conference News AHA 2024 Spironolactone No Help for the Heart After Acute MI: CLEAR SYNERGY Shelley Wood November 17, 2024
Presentation AHA 2024 Routine spironolactone in Acute Myocardial Infarction, results from the CLEAR SYNERGY OASIS 9 trial Presenter: Sanjit S Jolly November 17, 2024
News Conference News AHA 2024 US Obesity Epidemic Continues to Skyrocket, With No End in Sight Michael O'Riordan November 15, 2024
News Daily News Rosuvastatin Bests Atorvastatin for Reducing CVD Risk: Registry Data Michael O'Riordan November 07, 2024